Global Influenza Virus Vaccine (H1N1) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 48959
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Influenza Virus Vaccine (H1N1) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Influenza Virus Vaccine (H1N1) size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Influenza Virus Vaccine (H1N1) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Influenza Virus Vaccine (H1N1) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Intramuscular Vaccine

Nasal Spray Vaccine

Market segment by Application can be divided into

3 To 10 Years Old

10 To 18 Years Old

Above 18 Years Old

Other

The key market players for global Influenza Virus Vaccine (H1N1) market are listed below:

CSL

NVS(Novartis)

Sanofi Pasteur

Medimmune

GSK

Baxter

Beijing Kexing Bio-Vaccine

Hualan Bio-Vaccine

Changchun Changsheng Bio-Technology

Beijing Tiantan Bio-Products

Jiangsu Yanshen Bio-Technology

Zhejiang Tianyuan Bio-Pharmaceutical

Dalian Yalifeng Bio-Pharmaceutical

Sinopharm

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Influenza Virus Vaccine (H1N1) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Influenza Virus Vaccine (H1N1), with price, sales, revenue and global market share of Influenza Virus Vaccine (H1N1) in 2018 and 2019.

Chapter 3, the Influenza Virus Vaccine (H1N1) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Influenza Virus Vaccine (H1N1) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Influenza Virus Vaccine (H1N1) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Influenza Virus Vaccine (H1N1) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Influenza Virus Vaccine (H1N1) Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Influenza Virus Vaccine (H1N1) Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Intramuscular Vaccine

1.2.3 Nasal Spray Vaccine

1.3 Market Analysis by Application

1.3.1 Overview: Global Influenza Virus Vaccine (H1N1) Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 3 To 10 Years Old

1.3.3 10 To 18 Years Old

1.3.4 Above 18 Years Old

1.3.5 Other

1.4 Global Influenza Virus Vaccine (H1N1) Market Size & Forecast

1.4.1 Global Influenza Virus Vaccine (H1N1) Sales in Value (2016-2026))

1.4.2 Global Influenza Virus Vaccine (H1N1) Sales in Volume (2016-2026)

1.4.3 Global Influenza Virus Vaccine (H1N1) Price by Type (2016-2026) & (US$/Dose)

1.5 Global Influenza Virus Vaccine (H1N1) Production Capacity Analysis

1.5.1 Global Influenza Virus Vaccine (H1N1) Total Production Capacity (2016-2026)

1.5.2 Global Influenza Virus Vaccine (H1N1) Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Influenza Virus Vaccine (H1N1) Market Drivers

1.6.2 Influenza Virus Vaccine (H1N1) Market Restraints

1.6.3 Influenza Virus Vaccine (H1N1) Trends Analysis

2 Manufacturers Profiles

2.1 CSL

2.1.1 CSL Details

2.1.2 CSL Major Business

2.1.3 CSL Influenza Virus Vaccine (H1N1) Product and Services

2.1.4 CSL Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 NVS(Novartis)

2.2.1 NVS(Novartis) Details

2.2.2 NVS(Novartis) Major Business

2.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product and Services

2.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Sanofi Pasteur

2.3.1 Sanofi Pasteur Details

2.3.2 Sanofi Pasteur Major Business

2.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product and Services

2.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Medimmune

2.4.1 Medimmune Details

2.4.2 Medimmune Major Business

2.4.3 Medimmune Influenza Virus Vaccine (H1N1) Product and Services

2.4.4 Medimmune Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 GSK

2.5.1 GSK Details

2.5.2 GSK Major Business

2.5.3 GSK Influenza Virus Vaccine (H1N1) Product and Services

2.5.4 GSK Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Baxter

2.6.1 Baxter Details

2.6.2 Baxter Major Business

2.6.3 Baxter Influenza Virus Vaccine (H1N1) Product and Services

2.6.4 Baxter Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Beijing Kexing Bio-Vaccine

2.7.1 Beijing Kexing Bio-Vaccine Details

2.7.2 Beijing Kexing Bio-Vaccine Major Business

2.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product and Services

2.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Hualan Bio-Vaccine

2.8.1 Hualan Bio-Vaccine Details

2.8.2 Hualan Bio-Vaccine Major Business

2.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product and Services

2.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Changchun Changsheng Bio-Technology

2.9.1 Changchun Changsheng Bio-Technology Details

2.9.2 Changchun Changsheng Bio-Technology Major Business

2.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product and Services

2.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Beijing Tiantan Bio-Products

2.10.1 Beijing Tiantan Bio-Products Details

2.10.2 Beijing Tiantan Bio-Products Major Business

2.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product and Services

2.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 Jiangsu Yanshen Bio-Technology

2.11.1 Jiangsu Yanshen Bio-Technology Details

2.11.2 Jiangsu Yanshen Bio-Technology Major Business

2.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product and Services

2.11.4 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Zhejiang Tianyuan Bio-Pharmaceutical

2.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Details

2.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Major Business

2.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product and Services

2.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 Dalian Yalifeng Bio-Pharmaceutical

2.13.1 Dalian Yalifeng Bio-Pharmaceutical Details

2.13.2 Dalian Yalifeng Bio-Pharmaceutical Major Business

2.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product and Services

2.13.4 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 Sinopharm

2.14.1 Sinopharm Details

2.14.2 Sinopharm Major Business

2.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Product and Services

2.14.4 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Influenza Virus Vaccine (H1N1) Sales by Manufacturer

3.1 Global Influenza Virus Vaccine (H1N1) Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Influenza Virus Vaccine (H1N1)

3.4 Market Concentration Rate

3.4.1 Top 3 Influenza Virus Vaccine (H1N1) Manufacturer Market Share

3.4.2 Top 6 Influenza Virus Vaccine (H1N1) Manufacturer Market Share

3.5 Global Influenza Virus Vaccine (H1N1) Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Influenza Virus Vaccine (H1N1) Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Influenza Virus Vaccine (H1N1) Market Size by Region

4.1.1 Global Influenza Virus Vaccine (H1N1) Sales in Volume by Region (2016-2026)

4.1.2 Global Influenza Virus Vaccine (H1N1) Revenue by Region (2016-2026)

4.2 North America Influenza Virus Vaccine (H1N1) Revenue (2016-2026)

4.3 Europe Influenza Virus Vaccine (H1N1) Revenue (2016-2026)

4.4 Asia-Pacific Influenza Virus Vaccine (H1N1) Revenue (2016-2026)

4.5 South America Influenza Virus Vaccine (H1N1) Revenue (2016-2026)

4.6 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Influenza Virus Vaccine (H1N1) Sales in Volume by Type (2016-2026)

5.2 Global Influenza Virus Vaccine (H1N1) Revenue by Type (2016-2026)

5.3 Global Influenza Virus Vaccine (H1N1) Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Influenza Virus Vaccine (H1N1) Sales in Volume by Application (2016-2026)

6.2 Global Influenza Virus Vaccine (H1N1) Revenue by Application (2016-2026)

6.3 Global Influenza Virus Vaccine (H1N1) Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Influenza Virus Vaccine (H1N1) Sales by Type (2016-2026)

7.2 North America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2026)

7.3 North America Influenza Virus Vaccine (H1N1) Market Size by Country

7.3.1 North America Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2016-2026)

7.3.2 North America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Influenza Virus Vaccine (H1N1) Sales by Type (2016-2026)

8.2 Europe Influenza Virus Vaccine (H1N1) Sales by Application (2016-2026)

8.3 Europe Influenza Virus Vaccine (H1N1) Market Size by Country

8.3.1 Europe Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2016-2026)

8.3.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Type (2016-2026)

9.2 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2016-2026)

9.3 Asia-Pacific Influenza Virus Vaccine (H1N1) Market Size by Region

9.3.1 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Influenza Virus Vaccine (H1N1) Sales by Type (2016-2026)

10.2 South America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2026)

10.3 South America Influenza Virus Vaccine (H1N1) Market Size by Country

10.3.1 South America Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2016-2026)

10.3.2 South America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Type (2016-2026)

11.2 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Application (2016-2026)

11.3 Middle East & Africa Influenza Virus Vaccine (H1N1) Market Size by Country

11.3.1 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Influenza Virus Vaccine (H1N1) Typical Distributors

12.3 Influenza Virus Vaccine (H1N1) Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Influenza Virus Vaccine (H1N1) Revenue by Type, (USD Million), 2021-2026

Table 2. Global Influenza Virus Vaccine (H1N1) Revenue by Application, (USD Million), 2021-2026

Table 3. CSL Basic Information, Manufacturing Base and Competitors

Table 4. CSL Major Business

Table 5. CSL Influenza Virus Vaccine (H1N1) Product and Services

Table 6. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. NVS(Novartis) Basic Information, Manufacturing Base and Competitors

Table 8. NVS(Novartis) Major Business

Table 9. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product and Services

Table 10. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors

Table 12. Sanofi Pasteur Major Business

Table 13. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product and Services

Table 14. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Medimmune Basic Information, Manufacturing Base and Competitors

Table 16. Medimmune Major Business

Table 17. Medimmune Influenza Virus Vaccine (H1N1) Product and Services

Table 18. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. GSK Basic Information, Manufacturing Base and Competitors

Table 20. GSK Major Business

Table 21. GSK Influenza Virus Vaccine (H1N1) Product and Services

Table 22. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Baxter Basic Information, Manufacturing Base and Competitors

Table 24. Baxter Major Business

Table 25. Baxter Influenza Virus Vaccine (H1N1) Product and Services

Table 26. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Beijing Kexing Bio-Vaccine Basic Information, Manufacturing Base and Competitors

Table 28. Beijing Kexing Bio-Vaccine Major Business

Table 29. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product and Services

Table 30. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Hualan Bio-Vaccine Basic Information, Manufacturing Base and Competitors

Table 32. Hualan Bio-Vaccine Major Business

Table 33. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product and Services

Table 34. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Changchun Changsheng Bio-Technology Basic Information, Manufacturing Base and Competitors

Table 36. Changchun Changsheng Bio-Technology Major Business

Table 37. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product and Services

Table 38. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Beijing Tiantan Bio-Products Basic Information, Manufacturing Base and Competitors

Table 40. Beijing Tiantan Bio-Products Major Business

Table 41. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product and Services

Table 42. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Jiangsu Yanshen Bio-Technology Basic Information, Manufacturing Base and Competitors

Table 44. Jiangsu Yanshen Bio-Technology Major Business

Table 45. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product and Services

Table 46. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 48. Zhejiang Tianyuan Bio-Pharmaceutical Major Business

Table 49. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product and Services

Table 50. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. Dalian Yalifeng Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 52. Dalian Yalifeng Bio-Pharmaceutical Major Business

Table 53. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product and Services

Table 54. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Sinopharm Basic Information, Manufacturing Base and Competitors

Table 56. Sinopharm Major Business

Table 57. Sinopharm Influenza Virus Vaccine (H1N1) Product and Services

Table 58. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. Global Influenza Virus Vaccine (H1N1) Sales by Manufacturer (2019-2021e) & (K Doses)

Table 60. Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 61. Market Position of Manufacturers in Influenza Virus Vaccine (H1N1), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 62. Global Influenza Virus Vaccine (H1N1) Production Capacity by Company, (K Doses): 2020 VS 2021

Table 63. Head Office and Influenza Virus Vaccine (H1N1) Production Site of Key Manufacturer

Table 64. Influenza Virus Vaccine (H1N1) New Entrant and Capacity Expansion Plans

Table 65. Influenza Virus Vaccine (H1N1) Mergers & Acquisitions in the Past Five Years

Table 66. Global Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021e) & (K Doses)

Table 67. Global Influenza Virus Vaccine (H1N1) Sales by Region (2021-2026) & (K Doses)

Table 68. Global Influenza Virus Vaccine (H1N1) Revenue by Region (2016-2021e) & (USD Million)

Table 69. Global Influenza Virus Vaccine (H1N1) Revenue by Region (2021-2026) & (USD Million)

Table 70. Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021e) & (K Doses)

Table 71. Global Influenza Virus Vaccine (H1N1) Sales by Type (2021-2026) & (K Doses)

Table 72. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2016-2021e) & (USD Million)

Table 73. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2021-2026) & (USD Million)

Table 74. Global Influenza Virus Vaccine (H1N1) Price by Type (2016-2021e) & (US$/Dose)

Table 75. Global Influenza Virus Vaccine (H1N1) Price by Type (2021-2026) & (US$/Dose)

Table 76. Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021e) & (K Doses)

Table 77. Global Influenza Virus Vaccine (H1N1) Sales by Application (2021-2026) & (K Doses)

Table 78. Global Influenza Virus Vaccine (H1N1) Revenue by Application (2016-2021e) & (USD Million)

Table 79. Global Influenza Virus Vaccine (H1N1) Revenue by Application (2021-2026) & (USD Million)

Table 80. Global Influenza Virus Vaccine (H1N1) Price by Application (2016-2021e) & (US$/Dose)

Table 81. Global Influenza Virus Vaccine (H1N1) Price by Application (2021-2026) & (US$/Dose)

Table 82. North America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021e) & (K Doses)

Table 83. North America Influenza Virus Vaccine (H1N1) Sales by Country (2021-2026) & (K Doses)

Table 84. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021e) & (USD Million)

Table 85. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2021-2026) & (USD Million)

Table 86. North America Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021e) & (K Doses)

Table 87. North America Influenza Virus Vaccine (H1N1) Sales by Type (2021-2026) & (K Doses)

Table 88. North America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021e) & (K Doses)

Table 89. North America Influenza Virus Vaccine (H1N1) Sales by Application (2021-2026) & (K Doses)

Table 90. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021e) & (K Doses)

Table 91. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2021-2026) & (K Doses)

Table 92. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021e) & (USD Million)

Table 93. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2021-2026) & (USD Million)

Table 94. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021e) & (K Doses)

Table 95. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2021-2026) & (K Doses)

Table 96. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021e) & (K Doses)

Table 97. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2021-2026) & (K Doses)

Table 98. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021e) & (K Doses)

Table 99. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2021-2026) & (K Doses)

Table 100. Asia-Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2016-2021e) & (USD Million)

Table 101. Asia-Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2021-2026) & (USD Million)

Table 102. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021e) & (K Doses)

Table 103. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Type (2021-2026) & (K Doses)

Table 104. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021e) & (K Doses)

Table 105. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2021-2026) & (K Doses)

Table 106. South America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021e) & (K Doses)

Table 107. South America Influenza Virus Vaccine (H1N1) Sales by Country (2021-2026) & (K Doses)

Table 108. South America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021e) & (USD Million)

Table 109. South America Influenza Virus Vaccine (H1N1) Revenue by Country (2021-2026) & (USD Million)

Table 110. South America Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021e) & (K Doses)

Table 111. South America Influenza Virus Vaccine (H1N1) Sales by Type (2021-2026) & (K Doses)

Table 112. South America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021e) & (K Doses)

Table 113. South America Influenza Virus Vaccine (H1N1) Sales by Application (2021-2026) & (K Doses)

Table 114. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021e) & (K Doses)

Table 115. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Country (2021-2026) & (K Doses)

Table 116. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021e) & (USD Million)

Table 117. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2021-2026) & (USD Million)

Table 118. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021e) & (K Doses)

Table 119. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Type (2021-2026) & (K Doses)

Table 120. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021e) & (K Doses)

Table 121. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Application (2021-2026) & (K Doses)

Table 122. Direct Channel Pros & Cons

Table 123. Indirect Channel Pros & Cons

Table 124. Influenza Virus Vaccine (H1N1) Typical Distributors

Table 125. Influenza Virus Vaccine (H1N1) Typical Customers

List of Figures

Figure 1. Influenza Virus Vaccine (H1N1) Picture

Figure 2. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2020

Figure 3. Intramuscular Vaccine

Figure 4. Nasal Spray Vaccine

Figure 5. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2020

Figure 6. 3 To 10 Years Old

Figure 7. 10 To 18 Years Old

Figure 8. Above 18 Years Old

Figure 9. Other

Figure 10. Global Influenza Virus Vaccine (H1N1) Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026

Figure 11. Global Influenza Virus Vaccine (H1N1) Market Size and Forecast (2016-2026) & (USD Million)

Figure 12. Global Influenza Virus Vaccine (H1N1) Sales (2016-2026) & (K Doses)

Figure 13. Global Influenza Virus Vaccine (H1N1) Price by Type (2016-2026) & (US$/Dose)

Figure 14. Global Influenza Virus Vaccine (H1N1) Production Capacity (2016-2026) & (K Doses)

Figure 15. Global Influenza Virus Vaccine (H1N1) Production Capacity by Geographic Region: 2020 VS 2021

Figure 16. Influenza Virus Vaccine (H1N1) Market Drivers

Figure 17. Influenza Virus Vaccine (H1N1) Market Restraints

Figure 18. Influenza Virus Vaccine (H1N1) Market Trends

Figure 19. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturer in 2020

Figure 20. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Manufacturer in 2020

Figure 21. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. Top 3 Influenza Virus Vaccine (H1N1) Manufacturer (Revenue) Market Share in 2020

Figure 23. Top 6 Influenza Virus Vaccine (H1N1) Manufacturer (Revenue) Market Share in 2020

Figure 24. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2016-2026)

Figure 25. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2016-2026)

Figure 26. North America Influenza Virus Vaccine (H1N1) Revenue (2016-2026) & (USD Million)

Figure 27. Europe Influenza Virus Vaccine (H1N1) Revenue (2016-2026) & (USD Million)

Figure 28. Asia-Pacific Influenza Virus Vaccine (H1N1) Revenue (2016-2026) & (USD Million)

Figure 29. South America Influenza Virus Vaccine (H1N1) Revenue (2016-2026) & (USD Million)

Figure 30. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue (2016-2026) & (USD Million)

Figure 31. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2026)

Figure 32. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2016-2026)

Figure 33. Global Influenza Virus Vaccine (H1N1) Price by Type (2016-2026) & (US$/Dose)

Figure 34. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2026)

Figure 35. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2016-2026)

Figure 36. Global Influenza Virus Vaccine (H1N1) Price by Application (2016-2026) & (US$/Dose)

Figure 37. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2026)

Figure 38. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2026)

Figure 39. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2016-2026)

Figure 40. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2016-2026)

Figure 41. United States Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Canada Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Mexico Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2026)

Figure 45. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2026)

Figure 46. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2016-2026)

Figure 47. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2016-2026)

Figure 48. Germany Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. France Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. United Kingdom Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Russia Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Italy Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2016-2026)

Figure 54. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2026)

Figure 55. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2016-2026)

Figure 56. Asia-Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2016-2026)

Figure 57. China Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Japan Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Korea Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. India Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Southeast Asia Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Australia Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South America Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2026)

Figure 64. South America Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2026)

Figure 65. South America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2016-2026)

Figure 66. South America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2016-2026)

Figure 67. Brazil Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Argentina Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2026)

Figure 70. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2026)

Figure 71. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2016-2026)

Figure 72. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2016-2026)

Figure 73. Turkey Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Egypt Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Saudi Arabia Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. South Africa Influenza Virus Vaccine (H1N1) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Sales Channel: Direct Channel vs Indirect Channel

Figure 78. Methodology

Figure 79. Research Process and Data Source